Cleared Traditional

K992710 - ABBOTT ARCHITECH GLYCATED HEMOGLOBIN MA...

K992710 is an FDA 510(k) clearance for ABBOTT ARCHITECH GLYCATED HEMOGLOBIN MA..., manufactured by Abbott Laboratories. The device is a Class 1 Immunology device with product code JJY cleared through the Traditional 510(k) pathway after a 105-day FDA review.

K992710 · Abbott Laboratories · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1999
Decision
105d
Days
Class 1
Risk

K992710 is an FDA 510(k) clearance for the ABBOTT ARCHITECH GLYCATED HEMOGLOBIN MASTERCHECK. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on November 24, 1999 after a review of 105 days - within the typical 510(k) review window.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K992710

510(k) Number K992710 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 11, 1999
Decision Date November 24, 1999
Days to Decision 105 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1d slower than avg
Panel avg: 104d · This submission: 105d
Pathway characteristics
Predicate-based equivalence.

JJY Device Classification - Class 1, General Controls

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 515
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K992710.
APOLIPOPROTEIN CONTROL SERUM CHD, MODEL OUPH
K993310 · Dade Behring, Inc. · Nov 1999
TRI-POINT, LIQUIMMUNE LIQUID ASSAYED IMMUNOASSAY CONTROL, LEVELS 1, 2, AND 3
K993546 · Medical Analysis Systems, Inc. · Nov 1999
SYNCHRON SYSTEMS OP 300 LOW AND HIGH URINE CONTROLS
K993023 · Beckman Coulter, Inc. · Nov 1999
PRECINORM UNIVERSAL AND PRECIPATH UNIVERSAL CONTROL SERA
K992900 · Roche Diagnostics Corp. · Nov 1999
PRECINORM UNIVERSAL PLUS AND PRECIPATH UNIVERSAL PLUS CONTROL SERA
K993360 · Roche Diagnostics Corp. · Nov 1999
LYPHOCHEK ANEMIA CONTROL, MODEL 500
K992741 · Bio-Rad · Nov 1999